Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI

Aminophylline shortages led us to compare intravenous (iv) aminophylline with iv and oral (po) caffeine during routine pharmacologic stress testing with spect mpi. we measured presence, duration, and reversal of adverse symptoms and cardiac events following regadenoson administration in consecutive patients randomized to iv aminophylline (100 mg administered over 30-60 seconds), iv caffeine citrate (60 mg infused over 3-5 minutes), or po caffeine as coffee or diet cola. of 241 patients, 152 (63%) received regadenoson reversal intervention. complete (cr), predominant (pre), or partial (pr) reversal was observed in 99%. cr by iv aminophylline (87%), iv caffeine (87%), and po caffeine (78%) were similar (p = ns). time to cr (162 ± 12.6 seconds, mean ± sd) was similar in treatment arms. po caffeine was inferior to iv aminophylline for cr + pre. iv aminophylline and iv caffeine provide rapid, safe reversal of regadenoson-induced adverse effects during spect mpi. oral caffeine appeared similarly effective for cr but not for the combined cr + pre. our results suggest po caffeine be an effective initial strategy for reversal of regadenoson, but iv aminophylline or iv caffeine should be available to optimize symptom reversal as needed.